Submit Essay

Once you submit your essay, you can no longer edit it.

# UK Covid herd immunity (53.3m) date

### Question

Two vaccines against SARS-CoV-2 have been approved for use in the UK and the vaccination programme is underway. The Pfizer/BioNTech vaccine has an estimated efficacy of ~95% and the Oxford/AstraZeneca vaccine has an estimated efficacy of 62%-90%, depending on the dosing schedule.

Herd immunity is expected to be reached when a sufficient proportion of the population has become immune to the virus, either through vaccination or past infection. Current research suggests that the herd immunity threshold for this virus is 60%-70%.

However, recent evidence indicates that a more transmissible variant of SARS-CoV-2 has become dominant in the UK, which could raise the herd immunity threshold.

When will the UK reach herd immunity >53.3m for Covid-19?

This question resolves as the date when the first reliable media report is published stating that >53.3m people in the UK ($\approx$ 80% of the UK population) have either received a Sars-Cov-2 vaccine or been infected by the virus.

2 August clarification: This question will resolve as the date when a credible media report stating that the >53.3m immunity threshold has been reached is published, rather than the date when this threshold is reached.

Since the herd immunity threshold is difficult to ascertain, this question resolves when >80% of people have been vaccinated or infected. This value is taken to be a proxy for herd immunity.

### Prediction

Note: this question resolved before its original close time. All of your predictions came after the resolution, so you did not gain (or lose) any points for it.

Note: this question resolved before its original close time. You earned points up until the question resolution, but not afterwards.

Current points depend on your prediction, the community's prediction, and the result. Your total earned points are averaged over the lifetime of the question, so predict early to get as many points as possible! See the FAQ.